Schedule & Agenda

World-class education program, delivered in person in San Diego, CA

Programming Hours (All Times Pacfic)

Monday, June 13

8:30 AM - 5:00 PM

Tuesday, June 14

8:30 AM - 5:00 PM

Wednesday, June 15

9:00 AM - 5:30 PM

Thursday, June 16

9:00 AM - 5:30 PM

 

BIO International Convention
Date
  • Show All
Time
  • Show All
  • Show All
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO International Convention
Jump to Day
98 Results
Monday, June 13
1:00 PM - 2:00 PM (PDT)
What do biotech companies need to consider as they develop the next breakthrough treatment for…
Upper Level, Session Room 2
When Vividion examined the next steps for their company, an IPO was the path forward. Until one day…
Upper Level, Session Room 3
Pre-POC biotechs, including platform companies, are increasingly recognizing the importance of…
Upper Level, Session Room 6C
In late 2020, FDA announced that it had awarded four grants to researchers to examine the use of…
Upper Level, Session Room 5A
The biotechnology industry touches every part of our lives, from the medicines helping patients,…
Upper Level, Session Room 7B
In the Business Development and Transactions community, we often focus on the big splashy asset or …
Upper Level, Session Room 6F
Conducting a successful clinical trial for orphan and rare diseases presents unique challenges…
Upper Level, Session Room 11A
Learn how different organizations are approaching using AI/ML, their thoughts on the challenges and…
Upper Level, Session Room 5B
2:15 PM - 3:15 PM (PDT)
In March 2022, the Biopharma Sustainability Roundtable (BRST) published an expanded resource for…
Upper Level, Session Room 7B
With the delivery of mRNA-based COVID-19 vaccines, mRNA earned its rightful place among the leading…
Upper Level, Session Room 3
Individualized antisense oligonucleotide (ASO) technology is increasingly capturing the attention…
Upper Level, Session Room 11A
ORBIS has demonstrated success and seems to function as a forum for other global regulators to…
Upper Level, Session Room 6C
Regulatory guidance to support submission of high validity and relevance of real-world evidence …
Upper Level, Session Room 5A
A key question facing pre-commercial emerging pharma and biotech company leadership and directors…
Upper Level, Session Room 6F
While COVID-19 only first emerged in 2019, influenza has been plaguing humanity for centuries…
Upper Level, Session Room 8
3:30 PM - 4:30 PM (PDT)
AACR Project GENIE is an open-source, international, pancancer registry of real-world data…
Upper Level, Session Room 6C
Global health inequity has many dimensions, and strategies are needed to address each of these…
Upper Level, Session Room 2
As we begin to enter an endemic phase of COVID-19, we are reflecting on the triumphs, challenges…
Upper Level, Session Room 8
Tuesday, June 14
11:00 AM - 12:00 PM (PDT)
 Although specific aspects of clinical trials decentralization were in place before the…
Upper Level, Session Room 3
Our nation’s newborn screening system is a public health success but increasingly lags far…
Upper Level, Session Room 6C
Life sciences and healthcare companies are leveraging machine learning and AI for new advancements…
Upper Level, Session Room 4
As several new therapies originating in China begin reaching the review and regulatory approval…
Upper Level, Session Room 6D
Recent collaborations and financing deals involving small-mid biotechs and big pharmaceutical firms…
Upper Level, Session Room 11A
Genomic medicines continues to move to the forefront with an expected growth to $95B in 2028 (from …
Upper Level, Session Room 5A
Patient advocacy organizations (PAOs) are increasingly offering sophisticated resources and…
Upper Level, Session Room 7B
Aging is the primary risk factor for many chronic conditions, and diseases of aging represent an…
Upper Level, Session Room 1B
The COVID-19 pandemic has been a catalyst for vaccine innovation, with both the development of…
Upper Level, Session Room 8
Emerging biotechs applying today’s revolutionary technologies face two interrelated questions…
Upper Level, Session Room 6F
1:45 PM - 2:45 PM (PDT)
The rare disease patient undergoes a diagnostic odyssey that takes five to eight years on average,…
Upper Level, Session Room 6C
Complex Innovative Design – what’s in a name? A global perspective on the changing…
Upper Level, Session Room 5A
Diagnostics and research tools are informing novel vaccine development like the COVID mRNA vaccines…
Upper Level, Session Room 8
Enhancing diversity and inclusion in clinical studies is critical to closing the health equity gap…
Upper Level, Session Room 2
Hemostasis and thrombosis are believed to be so intricately linked that any strategies that reduce…
Upper Level, Session Room 1B
Strategic partnerships are critical for driving digital health innovation forward. Join us for an…
Upper Level, Session Room 4
2020 was the year of the SPAC – raising nearly double what was raised over the course of the…
Upper Level, Session Room 6D
Given a less than 8% likelihood for a New Drug Approval from first in man clinical trials, drug…
Upper Level, Session Room 3
1:45 PM - 3:00 PM (PDT)
The current pandemic has created a national discussion about the fragility of global supply chains…
Upper Level, Session Room 5B
3:00 PM - 4:00 PM (PDT)
Over the course of the COVID-19 pandemic, vaccine developers worked with manufacturing partners…
Upper Level, Session Room 8
Partnerships between pharma and biotech hit record levels in 2021 both in terms of deals volume and…
Upper Level, Session Room 6F
While chronic diseases often pose persistent, daily challenges, many patients have few treatment…
Upper Level, Session Room 1B
Join us for an interactive roundtable discussion with the leaders of The Center for Drug Evaluation…
Upper Level, Session Room 5A
The challenge of health equity is common across healthcare systems, but it will require different…
Upper Level, Session Room 7B
Biotech brought the world innovation and cures and helped things get back to the new normal…
Upper Level, Session Room 6D
Join this panel of the leading investors in digital health to learn more about the 2022 investment…
Upper Level, Session Room 4
Economic marginalization can lead to gaps in access to healthcare and education, income disparities…
Upper Level, Session Room 2
The last 24 months have exposed business operations to unprecedented supply chain risks. Whether…
Upper Level, Session Room 3
In recent times, the epigenetic drug discovery field has made substantial progress. So far,…
Upper Level, Session Room 6C
4:15 PM - 5:15 PM (PDT)
Scientific breakthroughs during the pandemic are driving a lot of optimism around mRNA technology,…
Upper Level, Session Room 5A
 The inescapable visibility of health inequalities during the COVID-19 pandemic has animated…
Upper Level, Session Room 3
Women leaders have become increasingly more prominent throughout biotech in recent years, and these…
Upper Level, Session Room 7B
Creating an equitable and inclusive biotech ecosystem that fosters participation of individuals…
Upper Level, Session Room 2
Neurological disorders pose some of the greatest challenges and areas of unmet need in medicine…
Upper Level, Session Room 6C
The current stock market environment for small biotechs is tough even by historical standards. …
Upper Level, Session Room 6D
Now, the most critical assets of life sciences companies are data and information. They are virtual…
Upper Level, Session Room 4
4:15 PM - 4:45 PM (PDT)
David Thomas, BIO’s Vice President of Industry Analysis, will provide an overview of recent…
Upper Level, Session Room 6F
Wednesday, June 15
11:00 AM - 12:00 PM (PDT)
There has been tremendous progress in advancing gene therapies and delivering these life-changing…
Upper Level, Session Room 2
Vital Transformation will present new research supported by a BIO led consortium which quantifies…
Upper Level, Session Room 11A
 With a 90% failure rate and tens of billions in lost R&D costs every year, there is no…
Upper Level, Session Room 3
The urgency of the COVID-19 pandemic has accelerated the development, trial, and use of innovative…
Upper Level, Session Room 8
This panel of leading industry experts will discuss key considerations and experiences related to…
Upper Level, Session Room 1B
Protein degradation has emerged as one of the hottest areas of therapeutic research. Harnessing the…
Upper Level, Session Room 5A
Do you have what it takes to entice the industry’s top investors? Bring your A-game as you…
Upper Level, Session Room 6D
20 years ago, European pharmaceutical legislation underwent a major review, a critical point in the…
Upper Level, Session Room 7B
A discussion among panelists regarding the role of Big Data and AI at each stage of the drug…
Upper Level, Session Room 6C
 Prescription Digital Therapeutics (PDTs) present a novel opportunity for companies to develop…
Upper Level, Session Room 4
Join some of Pharma’s biggest dealmakers as they discuss the challenges, opportunities, and…
Upper Level, Session Room 6F
1:45 PM - 2:45 PM (PDT)
 Longevity tech is one of the fastest-growing yet relatively underserved markets worldwide…
Upper Level, Session Room 6D
Drug development remains a field defined by failure, with roughly 90% of products entering clinical…
Upper Level, Session Room 4
The value equation can be very different for patients with various conditions in different…
Upper Level, Session Room 6C
Diagnostic testing to identify patients who could benefit from targeted therapies is a cornerstone…
Upper Level, Session Room 3
Millions of people around the world are impacted by diseases of the brain — including…
Upper Level, Session Room 5B
Vaccines for COVID-19 were developed, produced and made available in developed countries in less…
Upper Level, Session Room 8
Executives can ignite change in the biotechnology ecosystem through strategic funding and company…
Upper Level, Session Room 5A
Biotech businesspeople who are inexperienced with biosimilars need a plain English explanation of…
Upper Level, Session Room 11A
The panel will explore the question as to whether crossover rounds are still needed to enter the U…
Upper Level, Session Room 6F
3:00 PM - 4:00 PM (PDT)
The remarkable convergence of advances in bioengineering and neurology has resulted in a fast…
Upper Level, Session Room 5B
Over the past decade, the scientific community has delivered an impressive pace of scientific…
Upper Level, Session Room 7B
This session will focus on considerations for evaluating the comparability of cell and gene therapy…
Upper Level, Session Room 1B
Recent successes in genetic medicine (regulatory approvals of Zolgensma and Luxturna, for example)…
Upper Level, Session Room 2
Join a distinguished panel of experts from U.S., EU, and China to discuss the extraordinary data…
Upper Level, Session Room 4
Many Life Sciences companies have become ever reliant on global supply chains in order to source…
Upper Level, Session Room 6D
 Commercial space activity is on the rise with advances in technologies that are lowering…
Upper Level, Session Room 5A
 In 2021, cancer diagnostics achieved a long-discussed “Holy Grail” milestone with…
Upper Level, Session Room 3
  Modern medicine as we know it is threatened by antimicrobial resistance (AMR). From common…
Upper Level, Session Room 8
Current value-based arrangements don’t address the stakeholder at the center of the issue …
Upper Level, Session Room 6C
Traditional drug development has involved fleets of scientists in lab coats.  But with…
Upper Level, Session Room 11A
4:15 PM - 5:15 PM (PDT)
Developing new therapeutics takes significant time and resources. Even when Federal agencies and…
Upper Level, Session Room 4
The identification of novel discoveries – ranging from cutting edge technologies to…
Upper Level, Session Room 3
Marwood Group estimates that there are more than 500 CDMOs globally and with more 45 large pharma…
Upper Level, Session Room 6D
Widespread evidence shows that cognitive problems are the second most commonly reported symptom …
Upper Level, Session Room 5B
Thursday, June 16
9:00 AM - 10:00 AM (PDT)
 Improvements in care benefit patients but make it harder to demonstrate survival gains in…
Upper Level, Session Room 6C
 Cellular therapies carry immense promise to provide treatment for previously unmet disease…
Upper Level, Session Room 2
Research universities are unparalleled generators of scientific knowledge and potentially impactful…
Upper Level, Session Room 3
The psychedelics industry has evolved from a stigmatized counterculture phenomenon to a…
Upper Level, Session Room 5A
10:15 AM - 11:15 AM (PDT)
During this session, we will provide an overview of the evolving science and AD DMT landscape,…
Upper Level, Session Room 5A
New federal funding tools to support translational research and bio tech hubs are being developed…
Upper Level, Session Room 3
Many life sciences companies offer programs to help patients afford their medications. But how can…
Upper Level, Session Room 6C
During recent years, a few challenges and risks to patients have been reported emerging from viral…
Upper Level, Session Room 2